Ingevity, Corp. (NGVT): Segall Bryant & Hamill, LLC added to its stake +15K shares

1.3M

Shares reported · +15K vs prior quarter

0.95%

Disclosed portfolio weight

$71.7M

Reported value

Holdings as of

Sep 30, 2025

Filed

Nov 12, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Oct 23, 2025Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On October 23, 2025, Ingevity Corporation (“Ingevity” or the “Company”) announced that it has appointed Ruth Castillo as Senior Vice President and President, Performance Materials of the Company, effective as of November 10, 2025.”
2. Nov 5, 2025Company filing · Form 8-K · ResultsReported its results

What came next

1. Dec 8, 2025Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On December 8, 2025, Ingevity Corporation (“Ingevity” or the “Company”) announced that Mary Dean Hall, Executive Vice President and Chief Financial Officer (“CFO”) of the Company, will transition from her current role, effective May 1, 2026.”
2. Jan 1, 2026Company filing · Form 8-K · Material agreement, Acquisition or saleCompleted buying or selling a business or assets, and signed an important agreement (and 1 more item)“The information provided under the Introductory Note and Item 1.01 in this Current Report on Form 8-K are incorporated by reference into this”
3. Feb 17, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On February 17, 2026, Jean S. Blackwell informed the Nominating & Governance Committee of the Board of Directors (the “Board”) of Ingevity Corporation (the “Company”) that she will not stand for election at the Company’s 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”).”
4. Feb 25, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Ingevity, Corp.

OQRO holds no insider, Congress, fund or contract record for Ingevity, Corp. dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its NGVT page.

How this filing works

• SEC Form 13F

Other disclosures at Ingevity, Corp.

• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 13, 2026
• SEC Form 13F-HRAug 12, 2026
• SEC Form 13F-HRMay 22, 2026
• SEC Form 13F-HRMay 15, 2026

Everything OQRO holds on this company is on its NGVT page.